Wettig Thane 4
4 · FIBROGEN INC · Filed Jan 10, 2025
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Wettig Thane
DirectorCEO
Transactions
- Award
Stock Option (Right to Buy)
2025-01-09+1,300,000→ 1,300,000 totalExercise: $0.65Exp: 2035-01-08→ Common Stock (1,300,000 underlying)
Footnotes (1)
- [F1]The option vests in equal amount quarterly over 4 years measured from 1/9/2025.